Type 1 is the enzyme variant primarily responsible for converting testosterone to DHT in hair-damaging locations, and this inhibition occurs with greater specificity for the hair-relevant type 1 than the prostate-relevant type 2
Consider using injection sites with more abundant subcutaneous tissue, such as the abdomen
Common side effects , particularly during the initial weeks of treatment, include: Nausea (reported in up to 20% of patients) Diarrhoea or constipation Decreased appetite Abdominal discomfort or bloating Fatigue or mild headache These gastrointestinal symptoms are usually mild to moderate and tend to diminish as the body adjusts to the medication, typically within 24 weeks
Nevertheless, individual responses can vary, and monitoring for effectiveness of both treatments remains important
Hypertens Res 49 , 19241938 (2026)
Oberg recognizes that joining a GLP-1 Treatments, Semaglutide or Tirzepatide medical weight loss program in Boulevard, CA, is a life-changing process